Amb a 1 immunostimulatory conjugate: Phase II

Dynavax reported that in a French Phase II trial of its AIC anti-allergy vaccine in 27 adults with ragweed allergies, a six-injection dose-ranging regimen was safe and well-tolerated. The company said...